228 related articles for article (PubMed ID: 8732666)
41. Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP.
vanderSpek JC; Sutherland JA; Zeng H; Battey JF; Jensen RT; Murphy JR
Cancer Res; 1997 Jan; 57(2):290-4. PubMed ID: 9000570
[TBL] [Abstract][Full Text] [Related]
42. Detection of gastrin-releasing peptide mRNA in small cell lung carcinomas and medullary thyroid carcinomas using synthetic oligodeoxyribonucleotide probes.
Suzuki M; Yamaguchi K; Abe K; Adachi N; Nagasaki K; Asanuma F; Adachi I; Kimura S; Terada M; Taya Y
Jpn J Clin Oncol; 1987 Jun; 17(2):157-63. PubMed ID: 3039200
[TBL] [Abstract][Full Text] [Related]
43. [The role of gastrin releasing peptide as a lung growth factor].
Thomas F; Morin A; Moreau JP; Calvo F; Poupon MF
Rev Mal Respir; 1992; 9(2):125-37. PubMed ID: 1565825
[TBL] [Abstract][Full Text] [Related]
44. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
Williams BY; Schonbrunn A
Cancer Res; 1994 Feb; 54(3):818-24. PubMed ID: 8306345
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical studies on gastrin-releasing peptide- and adrenocorticotropic hormone-containing cells in the human lung.
Tsutsumi Y; Osamura RY; Watanabe K; Yanaihara N
Lab Invest; 1983 May; 48(5):623-32. PubMed ID: 6188883
[TBL] [Abstract][Full Text] [Related]
46. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
Zhu YM; Webster SJ; Flower D; Woll PJ
Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
[TBL] [Abstract][Full Text] [Related]
48. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA
Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004
[TBL] [Abstract][Full Text] [Related]
49. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
[TBL] [Abstract][Full Text] [Related]
50. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
[TBL] [Abstract][Full Text] [Related]
51. Effects of bombesin on growth of human small cell lung carcinoma in vivo.
Alexander RW; Upp JR; Poston GJ; Gupta V; Townsend CM; Thompson JC
Cancer Res; 1988 Mar; 48(6):1439-41. PubMed ID: 2830965
[TBL] [Abstract][Full Text] [Related]
52. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer.
Oremek GM; Sapoutzis N
Anticancer Res; 2003; 23(2A):895-8. PubMed ID: 12820319
[TBL] [Abstract][Full Text] [Related]
53. Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines.
Verbeeck MA; Elands JP; de Leij LF; Buys CH; Carney DN; Bepler G; Roebroeck AJ; Van de Ven WJ; Burbach JP
Pathobiology; 1992; 60(3):136-42. PubMed ID: 1320893
[TBL] [Abstract][Full Text] [Related]
54. Gastrin releasing peptide in human neuroendocrine tumours.
Bostwick DG; Bensch KG
J Pathol; 1985 Dec; 147(4):237-44. PubMed ID: 3003308
[TBL] [Abstract][Full Text] [Related]
55. Simultaneous detection of messenger ribonucleic acids for bombesin/gastrin-releasing peptide and its receptor in rat brain by nonradiolabeled double in situ hybridization.
Wang D; Cutz E
Lab Invest; 1994 May; 70(5):775-80. PubMed ID: 8196371
[TBL] [Abstract][Full Text] [Related]
56. Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors.
Yamaguchi K; Abe K; Kameya T; Adachi I; Taguchi S; Otsubo K; Yanaihara N
Cancer Res; 1983 Aug; 43(8):3932-9. PubMed ID: 6861155
[TBL] [Abstract][Full Text] [Related]
57. Dexamethasone regulation of gastrin-releasing peptide receptor in human lung cells.
Novak J; Schleman S; Scott J; Balderman VL; Krech L; Kane MA
Lung Cancer; 2004 Jan; 43(1):17-28. PubMed ID: 14698533
[TBL] [Abstract][Full Text] [Related]
58. High affinity binding sites for gastrin releasing peptide on human gastric cancer and Ménétrier's mucosa.
Preston SR; Woodhouse LF; Jones-Blackett S; Wyatt JI; Primrose JN
Cancer Res; 1993 Nov; 53(21):5090-2. PubMed ID: 8221641
[TBL] [Abstract][Full Text] [Related]
59. Isolation of the bombesin/gastrin-releasing peptide receptor from human small cell lung carcinoma NCI-H345 cells.
Kane MA; Aguayo SM; Portanova LB; Ross SE; Holley M; Kelley K; Miller YE
J Biol Chem; 1991 May; 266(15):9486-93. PubMed ID: 1851748
[TBL] [Abstract][Full Text] [Related]
60. Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck.
Lango MN; Dyer KF; Lui VW; Gooding WE; Gubish C; Siegfried JM; Grandis JR
J Natl Cancer Inst; 2002 Mar; 94(5):375-83. PubMed ID: 11880476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
